Currently Viewing:
The American Journal of Managed Care November 2002
Therapeutic Options for the Management of Type 2 Diabetes Mellitus
Liza Takiya, PharmD, CDE, BCPS; Sweta Chawla, PharmD
Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices
Mary N. Walsh, MD; Ross J. Simpson, Jr, MD; George J. Wan, PhD, MPH; Thomas W. Weiss, DrPH; Charles M. Alexander, MD; Leona E. Markson, ScD;
Use of a Disease Severity Index for Evaluation of Healthcare Costs and Management of Comorbidities of Patients With Diabetes Mellitus
James L. Rosenzweig, MD; Katie Weinger, EdD; Laurinda Poirier-Solomon, MPH; Mary Rushton, MBA
Antibiotic Resistance: The Iowa Experience
Nancy Bell, RPh
State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection
Jane Nelson Bolin, PhD, JD, RN; Robert J. Buchanan, PhD; Scott R. Smith, PhD
When Do Developing Countries Adopt Managed Care Policies and Technologies? Part I: Policies, Experience, and a Framework of Preconditions
John W. Peabody, MD, PhD; Jeff Luck, MBA, PhD
Pill Splitting
R. Tim Webster, ScD. Author reply by Randall S. Stafford, MD, PhD; and David C. Radley, BA
Currently Reading
Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors
Diana Shye, PhD, MPH; Jonathan B. Brown, MPP, PhD; John P. Mullooly, PhD; Gregory A. Nichols, PhD

Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors

Diana Shye, PhD, MPH; Jonathan B. Brown, MPP, PhD; John P. Mullooly, PhD; Gregory A. Nichols, PhD
 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!